Additionally, emerging evidence suggests that interventions aimed at modulating GPR-120 activity, such as supplementation with specific omega-3 fatty acids, may offer a protective effect against the progression of DN [29,30]. This evidence concerns the gene FFAR4 and liver dysplastic nodule.